Log in to search using one of your social media accounts:

 

Celebrity doctor warns we should wear toxic sunscreen while talking on our cellphone or using our computer

(Natural News) The fear of getting skin cancer drives many people to wear sunscreen every time they leave the house, even if their plans don’t include spending time outdoors. The sunscreen industry has embraced this line of thinking, which is one big reason that Vitamin D deficiencies are soaring in this country. Melanoma is certainly...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

Authors: Gata VA, Lisencu CI, Vlad CI, Piciu D, Irimie A, Achimas-Cadariu P Abstract Malignant melanoma represents the major cause of mortality among skin cancers, with increasing incidence and mortality rates worldwide. Despite the numerous public health campaigns and the efforts undertaken in the last decade regarding the establishment of a rapid diagnostic and an efficient treatment for these patients, the long-term prognosis has not been significantly improved. Thus, numerous studies were conducted in order to establish a more accurate prognosis, tumor infiltrating lymphocytes (TILs) being considered in many st...
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
This article is protected by copyright. All rights reserved. Menadione based triazole hybrids were synthesized by employing copper catalyzed azide‐alkyne cycloaddition (CuAAC). The synthesized compounds were evaluated for their anticancer activity against five selected cancer cell lines. Compound 6 showed higher potency than the standard tamoxifen and parent menadione against MCF‐7 cell line, arrested cell cycle at G0/G1 phase and induced apoptotic cell death.
Source: Chemical Biology and Drug Design - Category: Biology Authors: Tags: Research Article Source Type: research
AbstractPurpose of ReviewRecent advances in the treatment of eyelid tumors have centered on the excision, evaluation of margins, role of sentinel lymph node biopsy, and adjunctive/adjuvant systemic and radiation therapy. The purpose of this review is to elaborate on these advances.Recent FindingsMohs excision of basal cell carcinoma and squamous cell carcinoma continues to provide the greatest success in complete excision of the cancer, especially in those cases of high-risk disease including medial canthal location and recurrent disease. Sentinel lymph node biopsy has proven useful in the assessment of early regional meta...
Source: Current Oncology Reports - Category: Cancer & Oncology Source Type: research
CONCLUSIONS: As the present project demonstrates, through the application of 3D printing technologies, the costs and time spent during the process in the clinical workload in brachytherapy treatment are reduced. Overall, 3D printing is a promising technique for brachytherapy that might be well received in the community. PMID: 28725252 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
CONCLUSIONS: This work is special, since the equipment's treatment voltage was 69.5 kV, and this is the first prospective study with long term follow-up with Esteya(®). These preliminary report show excellent results with less toxicity and excellent cosmesis. While surgery has been the treatment of choice, certain patients might benefit from eBT treatment. These are elderly patients with comorbidities or undergoing anticoagulant treatment as well as those who simply refuse surgery or might have other contraindications. PMID: 28725249 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
Three new dibenzoylmethane derivatives, (E)-3,4-methylenedioxy-2'-methoxy-2'',2''-dimethylpyrano-(5'',6'':3',4')-7-methoxychalcone, 2'-hydroxy-5'(3'''',3''''-dimethylallyl)-8-( α , α -dimethylallyl)-furano-(4'',5'':3'4')-dibenzoylmethane and 2'-O-(3'',3''-dimethylallyl)-8-( α , α -dimethylallyl)-furano-(4'',5'':3'4')-dibenzoylmethane, were isolated from a dichloromethane extract from the root bark of Muellera filipes (Benth.) M.J. Silva&A.M.G. Azevedo, along with two dibenzoylmethane derivatives, 2'-methoxy-8-( α , α -dimethylallyl)-furano-(4'',5'':3',4')-dibenzoylmethane and 2'-hydr...
Source: Journal of the Brazilian Chemical Society - Category: Chemistry Source Type: research
(University of Sussex) The Spencer Lab has been awarded a £ 428K grant to research a protein present in high amounts in melanoma.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(University of California - San Francisco) Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
ConclusionsPersonalized melanoma genomic risk information can prompt risk‐appropriate discussions about skin cancer prevention and skin examinations with family and health professionals. Sharing this information with others might increase its impact on melanoma prevention and skin examination behaviours, and this process could be used to encourage healthy behaviour change within families.
Source: British Journal of Dermatology - Category: Dermatology Authors: Tags: Qualitative Research Source Type: research
Authors: Mamdani H, Wu H, O'Neil BH, Sehdev A Abstract Hepatocellular carcinoma (HCC) is an aggressive cancer associated with high mortality worldwide. HCC develops in the setting of underlying cirrhosis due to chronic liver disease. Surgery is usually considered the treatment of choice for early disease; however, most patients have locally advanced or metastatic HCC at diagnosis in which case treatments are limited. Immune checkpoint blockade of programmed death receptor-1 (PD-1) pathway offers a potential treatment strategy based on the encouraging results of the phase I/II trial of nivolumab (Checkmate 040 trial...
Source: Discovery Medicine - Category: Research Tags: Discov Med Source Type: research
More News: Cancer | Cancer & Oncology | Computers | Melanoma | Skin | Skin Cancer | Toxicology | Vitamin D | Vitamins